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Relevance
The Novichok class of nerve agents are noxious chemical-weaponized 
organophosphates. Though its use is prohibited under the 1997 
Chemical Weapons Convention, the attempted murder of an ex-
Russian spy and his daughter has turned a spotlight on one of the 
world’s deadliest poisons. 
Summary
Novichok was developed by the Soviet Union in the 1970s and is 
reportedly ten times more lethal than VX, the nerve agent used 
to assassinate the half-brother of North Korean leader Kim Jong-
un. Novichok produces its toxic effect by irreversibly inhibiting 
acetylcholinesterase. Unlike other nerve agents, it is thought to target 
both the central and peripheral nervous systems. Exposure to Novichok 
invariably leads to death. 
Take Home Messages
With an increase in worldwide chemical weapons usage, including 
recent use in the United Kingdom, clinicians should know how to 
rapidly recognize symptoms of nerve agent poisoning, lend their 
expertise in the education and treatment of such attacks and administer 
life-saving antidotes.
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In March 2018, the United Kingdom, along with the rest of the 
world, were shocked by news of the poisoning of an ex-Russian 
spy. Less than three months later, paramedics were called to a flat in 
Amesbury, England, after a local couple were exposed to the very 
same agent used earlier in the year. (1) Subsequent confirmation 
that the substance used in these attacks belonged to the Novichok 
class of nerve agents has turned a spotlight on what are considered 
amongst the world’s deadliest chemical weapons. This article aims 
to explore Novichok and its effects on the human body, given the 
high likelihood of future usage of these agents.
The name Novichok means “newcomer” in Russian, highlighting 
the fact that its development marked a breakthrough in chemical 
weapons. (2) Novichok is a series of organophosphate nerve agents. 
Nerve agents are organic substances which disrupt the body’s 
normal nervous communication to muscles and organs. (1) 
Novichok was developed as part of the Russian classified nerve 
agent program named FOLIANT over a period of two decades 
from 1971. (3) It has never been used on the battlefield as its use is 
forbidden under the terms of the Chemical Weapons Convention 
of 1993. It is believed that Novichok was developed as the Soviet 
Union’s response to false information that the USA was producing 
its own nerve agents during the Cold War. (2,4)
The effects of Novichok, like all nerve agents, are due to the 
blocking of acetylcholinesterase (AChE) which catalyses the 
breakdown of acetylcholine (ACh). (4) ACh is a neurotransmitter 
found in vesicles of pre-synaptic neurons at neuromuscular 
junctions. As an action potential passes down a neuron, the 
depolarisation causes an influx of calcium ions, triggering 
exocytosis of ACh from the pre-synaptic neuron and diffusion 
across the synaptic cleft. ACh then binds onto nicotinic ACh 
receptors (nAChRs) on the post-synaptic membrane, causing 
sodium ion channels to open. An influx of sodium ions through 
the post-synaptic membrane causes depolarisation. The subsequent 
action potential results in contraction of a muscle or release of a 
hormone. Once the action has been produced, the enzyme AChE 
catabolises the neurotransmitter to allow the muscle or organ to 
relax. (See Figure 1) 
Figure 1 - Events at a neuromuscular junction
Novichok is a non-competitive inhibitor of AChE, accounting for 
its irreversible inactivation. (5) The nerve agent causes a build-up 
of ACh, preventing further re-depolarisation of the post-synaptic 
membrane, so that impulse transmission ceases. This results 
in muscles remaining in their contracted states. Symptoms of 
poisoning appear within seconds of exposure and death occurs 
rapidly by asphyxiation or cardiac arrest due to failure of contraction 
of the diaphragm and heart. Whilst most nerve agents affect the 
central nervous system exclusively, Novichok also affects the 
peripheral nervous system, leading to peripheral weakness and 
paraesthesia. (6)
Exposure to Novichok is generally by inhalation, although 
absorption may also occur percutaneously. (7) Early symptoms 
include rhinorrhea, chest tightness, and miosis. Later stages involve 
involuntary salivation, loss of continence and abdominal pain. This 
is followed by myoclonic jerks and status epilepticus. (6) If treatment 
is not initiated timely, death will ensue. Most of the literature on 
Novichok is based on testimonies from the scientists involved 
in developing the agent. As it is still a relatively new chemical 
which few people have been exposed to, our understanding of the 
symptomology and treatment are limited. Andrei Zheleznyakov, a 
scientist involved in the Novichok’s development, was accidentally 
exposed to the agent in 1987. He was unconscious for 10 days post-
exposure. Zheleznyakov then began to suffer from "chronic weakness 
in his arms, a toxic hepatitis that gave rise to cirrhosis of the liver, epilepsy, 
spells of severe depression, and an inability to read or concentrate that left him 
totally disabled and unable to work". (8) Five years following exposure, 
Zheleznyakov died.
“Circles appeared before my eyes: red and orange. A ringing in my ears, 
I caught my breath. And a sense of fear: like something was about to 
happen. I sat down on a chair and told the guys: it’s got me!” – Andrei 
Zheleznyakov, Russian military researcher after he was exposed to 
Novichok from a malfunctioning fume hood (1987). (8)
Initial management of Novichok poisoning includes removal of 
contaminated clothing and contact lenses. This should be followed 
by thorough rinsing of the skin with soap and water to prevent 
further exposure. Patients will then require basic life support and 
oxygen should be administered. (9) The mainstay treatment of 
Novichok poisoning is with anticholinergic drugs. (5) Atropine, an 
ACh receptor antagonist, blocks receptors to prevent poisoning.
Other antidotes include pralidoxime and diazepam. Pralidoxime 
binds to AChE causing the phosphate group of the nerve agent to 
be displaced. The poison/antidote complex then unbinds from the 
active site, thus regenerating the fully functional AChE enzyme. 
(10) It is possible to survive a Novichok attack; however, victims 
may be left with permanent disabilities such as chronic muscle 
weakness and reduced cognitive ability. 
Since its creation, seven people are known to have been exposed 
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by Novichok; of which three have died. Today, news of such 
chemical attacks is rapidly circulated and information about the 
poison and the risk of exposure can become misconstrued by the 
public. Therefore, it is increasingly important that clinicians can be 
called upon to lend their expertise in the education and treatment of 
attacks caused by dangerous chemical weapons.
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